These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 10763819)

  • 1. The promyelocytic leukemia (PML) protein suppresses cyclin D1 protein production by altering the nuclear cytoplasmic distribution of cyclin D1 mRNA.
    Lai HK; Borden KL
    Oncogene; 2000 Mar; 19(13):1623-34. PubMed ID: 10763819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma interferon and cadmium treatments modulate eukaryotic initiation factor 4E-dependent mRNA transport of cyclin D1 in a PML-dependent manner.
    Topisirovic I; Capili AD; Borden KL
    Mol Cell Biol; 2002 Sep; 22(17):6183-98. PubMed ID: 12167712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PML RING suppresses oncogenic transformation by reducing the affinity of eIF4E for mRNA.
    Cohen N; Sharma M; Kentsis A; Perez JM; Strudwick S; Borden KL
    EMBO J; 2001 Aug; 20(16):4547-59. PubMed ID: 11500381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 mRNA are increased in cells overexpressing eukaryotic initiation factor 4E.
    Rousseau D; Kaspar R; Rosenwald I; Gehrke L; Sonenberg N
    Proc Natl Acad Sci U S A; 1996 Feb; 93(3):1065-70. PubMed ID: 8577715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eukaryotic translation initiation factor 4E regulates expression of cyclin D1 at transcriptional and post-transcriptional levels.
    Rosenwald IB; Kaspar R; Rousseau D; Gehrke L; Leboulch P; Chen JJ; Schmidt EV; Sonenberg N; London IM
    J Biol Chem; 1995 Sep; 270(36):21176-80. PubMed ID: 7673150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The RING domains of the promyelocytic leukemia protein PML and the arenaviral protein Z repress translation by directly inhibiting translation initiation factor eIF4E.
    Kentsis A; Dwyer EC; Perez JM; Sharma M; Chen A; Pan ZQ; Borden KL
    J Mol Biol; 2001 Sep; 312(4):609-23. PubMed ID: 11575918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lymphocytic choriomeningitis virus RING protein Z associates with eukaryotic initiation factor 4E and selectively represses translation in a RING-dependent manner.
    Campbell Dwyer EJ; Lai H; MacDonald RC; Salvato MS; Borden KL
    J Virol; 2000 Apr; 74(7):3293-300. PubMed ID: 10708446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The promyelocytic leukemia protein stimulates SUMO conjugation in yeast.
    Quimby BB; Yong-Gonzalez V; Anan T; Strunnikov AV; Dasso M
    Oncogene; 2006 May; 25(21):2999-3005. PubMed ID: 16501610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. eIF4E is a central node of an RNA regulon that governs cellular proliferation.
    Culjkovic B; Topisirovic I; Skrabanek L; Ruiz-Gutierrez M; Borden KL
    J Cell Biol; 2006 Nov; 175(3):415-26. PubMed ID: 17074885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E.
    Rosenwald IB; Lazaris-Karatzas A; Sonenberg N; Schmidt EV
    Mol Cell Biol; 1993 Dec; 13(12):7358-63. PubMed ID: 8246956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cAMP signalling is decisive for recovery of nuclear bodies (PODs) during maturation of RA-resistant t(15;17) promyelocytic leukemia NB4 cells expressing PML-RAR alpha.
    Duprez E; Lillehaug JR; Naoe T; Lanotte M
    Oncogene; 1996 Jun; 12(11):2451-9. PubMed ID: 8649787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia.
    Boddy MN; Howe K; Etkin LD; Solomon E; Freemont PS
    Oncogene; 1996 Sep; 13(5):971-82. PubMed ID: 8806687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PML bodies: a meeting place for genomic loci?
    Ching RW; Dellaire G; Eskiw CH; Bazett-Jones DP
    J Cell Sci; 2005 Mar; 118(Pt 5):847-54. PubMed ID: 15731002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The PML/RARalpha fusion protein inhibits tumor necrosis factor-alpha-induced apoptosis in U937 cells and acute promyelocytic leukemia blasts.
    Testa U; Grignani F; Samoggia P; Zanetti C; Riccioni R; Lo Coco F; Diverio D; Felli N; Passerini CG; Grell M; Pelicci PG; Peschle C
    J Clin Invest; 1998 May; 101(10):2278-89. PubMed ID: 9593784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
    Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
    Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biologic function of PML and its role in acute promyelocytic leukemia.
    Mu ZM; Le XF; Glassman AB; Chang KS
    Leuk Lymphoma; 1996 Oct; 23(3-4):277-85. PubMed ID: 9031108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the promyelocytic leukemia body in the dynamic interaction between the androgen receptor and steroid receptor coactivator-1 in living cells.
    Rivera OJ; Song CS; Centonze VE; Lechleiter JD; Chatterjee B; Roy AK
    Mol Endocrinol; 2003 Jan; 17(1):128-40. PubMed ID: 12511612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Research advances on function of promyelocytic leukemia (PML) protein].
    He PC; Zhang M; Wang F
    Ai Zheng; 2003 Dec; 22(12):1359-62. PubMed ID: 14693070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pondering the promyelocytic leukemia protein (PML) puzzle: possible functions for PML nuclear bodies.
    Borden KL
    Mol Cell Biol; 2002 Aug; 22(15):5259-69. PubMed ID: 12101223
    [No Abstract]   [Full Text] [Related]  

  • 20. Cooperation between the RING + B1-B2 and coiled-coil domains of PML is necessary for its effects on cell survival.
    Fagioli M; Alcalay M; Tomassoni L; Ferrucci PF; Mencarelli A; Riganelli D; Grignani F; Pozzan T; Nicoletti I; Grignani F; Pelicci PG
    Oncogene; 1998 Jun; 16(22):2905-13. PubMed ID: 9671411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.